Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the […]